Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nivea is a globally recognized brand of personal care products, primarily known for its flagship product, Nivea Crème. It is a water-in-oil emulsion designed for topical application to hydrate and protect the skin. The formulation typically contains ingredients such as glycerin, panthenol, and eucerit (a lanolin-derived emulsifying agent). While primarily marketed as a cosmetic for the treatment of dry skin (xerosis), Nivea has been utilized in clinical research as a vehicle for drug delivery and as a standalone treatment in experimental models. Recent studies have demonstrated its efficacy in promoting wound healing in frostbite models, particularly when used as a base for active agents like sodium thiosulfate, where it supports re-epithelialization, granulation tissue formation, and the reduction of inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nivea.